COVID-19 pneumonia incidentally discovered on [18F]F-PSMA-1007 PET/CT scan.
Intissar El MoatassimOmar Ait SahelKenza BouzidiSalah Nabih OueriagliYassir BenameurJaafar El BakkaliAbderrahim DoudouhPublished in: Nuclear medicine review. Central & Eastern Europe (2024)
A 75-year-old man underwent a positron emission tomography/computed tomography (PET/CT) scan with fluorine-18-prostate specific membrane antigen ([¹⁸F]F-PSMA-1007) for initial staging of prostate adenocarcinoma. The scan showed lung infiltrates predominantly in both lower lobes with moderate uptake, in addition to a bilateral pulmonary hilar lymph node uptake. CT images revealed ground-glass opacities and a reticular pattern, suggesting COVID-19 pneumonia, which was confirmed by reverse transcription polymerase chain reaction (RT-PCR). Similar incidental findings have been reported in patients undergoing PET/CT scans with other radiotracers. In this case, the probable lung angiogenesis linked to COVID-19 infection can be potencially demonstrated by [¹⁸F]F-PSMA-1007, which helps ensure timely diagnosis and appropriate care for cancer patients.
Keyphrases
- pet ct
- positron emission tomography
- computed tomography
- coronavirus disease
- lymph node
- dual energy
- sars cov
- prostate cancer
- patients undergoing
- image quality
- contrast enhanced
- magnetic resonance imaging
- pet imaging
- benign prostatic hyperplasia
- healthcare
- pulmonary hypertension
- squamous cell carcinoma
- deep learning
- palliative care
- endothelial cells
- transcription factor
- quality improvement
- convolutional neural network
- high intensity
- neoadjuvant chemotherapy
- respiratory failure
- locally advanced
- magnetic resonance
- african american
- affordable care act
- radiation therapy
- early stage